Skip to main content
HCSG logo

HCSG · Healthcare Services Group Inc

Track HCSG — free
$23.00 +0.07 (+0.31%) At close · Aug 20
Market Cap
$1.57B
Shares
68.63M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$23.00 Open$22.70 Day$22.70–23.09 52W close$15.18–25.31 Avg vol 30d793K Short int2.6M · 3.8% float · 3.0d Short vol63% Last earningsJul 22, 2026 DataJan 2020–Aug 2026 Filing10-Q · Jul 24

Up next

Next earnings call
Oct 21, 2026 Est · unconfirmed · in 9 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed Jul 24, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Buy
      SellHoldBuy
      Technical Buy Momentum Strong Sentiment Neutral Fundamentals Excellent Quant / Vol Moderate
      Market backdrop VIX 14.9 · calm Equity put/call 0.52
      Technical
      price trend
      Buy
      50 / 200-day cross No cross
      Price vs 200-day avg +12%
      above
      Price vs 50-day avg −1%
      below
      RSI (14) 54
      neutral
      MACD trend Positive
      52-week position 77%
      mid-range
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Strong
      1-month return +3%
      trailing
      6-month return +6%
      trailing
      YTD return +20%
      this year
      Relative strength −6%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $23 › 200d $21 — 50d above 200d
      Institutional flow Accumulating
      +4% holders QoQ · +47 funds added
      Insider flow Distributing
      Net -$362.5K over 90 days · 100% sells
      Short interest Rising
      3.77% of float · ▲ +15.1% MoM · 3.0 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      271 holders — near 3-yr high, broad support
      Squeeze score 68
      elevated · 0–100
      Fundamentals
      Excellent
      Revenue growth +7%
      Y/Y
      EPS growth +53%
      Y/Y
      Free cash flow $139.2M
      Valuation P/E 13.4
      below peers
      Buyback $30.1M
      remaining
      Balance sheet $125.2M
      net cash
      Quant / Vol
      risk profile
      Moderate
      Volatility 43%
      annualized · 1-yr
      Max drawdown −20%
      past year
      ATR 3.4%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the 8-K filed Jul 22, 2026
      2026 effective tax rate · 2026 25%
      Effective tax rate · 2026 25%
      Prior guidance period ended · from the Earnings Call filed Mar 31, 2026
      Revenue · Q2 $465M – $475M
      Guided vs delivered · last 1 settled
      Q3 revenue Q3
      guided $420M – $430M
      $411.39M Miss −3.2%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Buy
      0 · 5 · 2
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +12% Bullish
      Price vs 50-day avg
      −1% Neutral
      RSI (14)
      54 Neutral
      MACD trend
      Positive Bullish
      52-week position
      77% Neutral
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Mixed
      Trend (MA cross) No cross
      50d $23 › 200d $21 — 50d above 200d
      Institutional flow Accumulating
      +4% holders QoQ · +47 funds added
      Insider flow Distributing
      Net -$362.5K over 90 days · 100% sells
      Short interest Rising
      3.77% of float · ▲ +15.1% MoM · 3.0 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      271 holders — near 3-yr high, broad support
      Price context
      position in its 52-week range
      Range low $15 Now $23 · 77% Range high $25
      vs 200-day avg +12% vs 50-day avg -1%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Adjusted EBITDA non-GAAP $74.44M Six Months Ended June 30, 2026
      Adjusted EBITDA as a percentage of revenue non-GAAP 8% Six Months Ended June 30, 2026
      EBITDA non-GAAP $68.86M Six Months Ended June 30, 2026

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Medical Care Facilities — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      HCSG
      Healthcare Services Group Inc
      this stock
      $1.57B +20.3% +7.1% 13.4 3.8%
      HCA
      HCA Healthcare, Inc.
      $90.30B -12.8% +7.1% 14.0 2.7%
      FSNUY
      Fresenius SE & Co. KGaA
      $30.84B -3.9% 0.0%
      THC
      Tenet Healthcare Corp
      $21.98B +35.1% +0.9% 10.5 4.0%
      FMS
      Fresenius Medical Care AG
      $12.69B -1.6% +5.9% 0.5%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Reducing
      Holders
      271
      % held
      104.0%
      Net QoQ
      -879.6K sh
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      330
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      2.6M
      Days to cover
      3.0d
      Change
      +340.7K sh
      View
      Short Volume
      Short vol %
      63%
      As of
      Aug 20, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      206
      Value
      $4.8K
      As of
      Jul 31, 2026
      View
      Off-Exchange
      Off-exchange %
      33.5%
      Week of
      Jul 13, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net selling
      Net (90d)
      -$362.5K
      Buyers / Sellers
      0 / 1
      Buyers Sellers
      View
      Congressional Trades Buy
      Member
      Greg Gianforte
      Amount
      $50.0K–$100.0K
      Traded
      Apr 30, 2020
      View
      Financials
      Financials
      Revenue (FY)
      $1.8B
      Net income (FY)
      $59.1M
      EPS diluted
      $0.81
      View
      Buybacks
      Authorized
      shares 10.0M
      Remaining
      $30.1M
      View
      Filings
      SEC Filings
      Latest
      10-Q
      Filed
      Jul 24, 2026
      This year
      9
      View
      Proposed Sales
      Value
      $362.5K
      Shares
      15.6K
      Filed
      Aug 4, 2026
      View
      Earnings & Events
      Earnings Calls
      Last call
      Jul 22, 2026
      View
      Investor Relations
      Latest news
      Healthcare Services Group Reports…
      Published
      Jul 22, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      HCSG +9.1% +2.5% +5.7% -1.3% +20.3%
      SPY -0.4% +2.9% +11.6% +3.0% +12.8%
      vs SPY +9.5% -0.4% -5.9% -4.2% +7.5%

      Capital returns

      Latest dividend
      $0.215 / share · ex Nov 17, 2022
      Raised 0.5%
      Paid (TTM)
      $0.00 / share · 0 payouts
      Dividend yield (TTM, derived)
      · no payout in the trailing year
      Buyback program · as of Jun 30, 2026
      Authorized
      shares 10.00M
      Spent (derived)
      Remaining
      $30.10M

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 731012 CUSIP 421906108 13F (30d) 251 filings 247 filers Visit website Investor relations